SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-000214
Filing Date
2021-01-21
Accepted
2021-01-21 16:32:44
Documents
8
Period of Report
2021-01-21

Document Format Files

Seq Description Document Type Size
1 6-K zk2125406.htm 6-K 25698
2 UNDERWRITING AGREEMENT exhibit_1-1.htm EX-99 291795
3 OPINION OF YIGAL ARNON & CO. exhibit_5-1.htm EX-5.1 23523
4 UNDERWRITER WARRANT exhibit_10-1.htm EX-99 97294
5 PRESS RELEASE DATED JANUARY 19, 2021 exhibit_99-1.htm EX-99.1 18229
6 PRESS RELEASE DATED JANUARY 20, 2021 exhibit_99-2.htm EX-99.2 19890
7 image00002.jpg GRAPHIC 4550
8 image00003.jpg GRAPHIC 22619
  Complete submission text file 0001178913-21-000214.txt   515218
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 21542401
SIC: 2834 Pharmaceutical Preparations